Management of dyslipidemia in the elderly population

Therapeutic Advances in Cardiovascular Disease

Volumn 4, Issue 6, 2010, Pages 375-383

  Gobal, Freij A ^a   Mehta, Jawahar L ^b  

^a CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Coronary heart disease; Dyslipidemia; Elderly; Prevention

Indexed keywords

ATORVASTATIN; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; NICOTINIC ACID; OMEGA 3 FATTY ACID; PHYTOSTEROL; PLACEBO; PRAVASTATIN; SIMVASTATIN; TORCETRAPIB; TRIACYLGLYCEROL;

ACUTE HEART INFARCTION; AGED; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DRUG ELIMINATION; DYSLIPIDEMIA; HEALTH CARE COST; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; LIPOPROTEIN METABOLISM; LOW FAT DIET; PATHOGENESIS; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK REDUCTION; SCREENING; SECONDARY PREVENTION; SEX DIFFERENCE;

AGE FACTORS; AGED; ANIMALS; CORONARY DISEASE; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS; MALE; MASS SCREENING; RISK FACTORS; SEX FACTORS;

EID: 78649367996     PISSN: 17539447     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753944710385048     Document Type: Review

References (41)

1. Adult Treatment Panel III (2002) Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Circulation 106: 3143-3421.
2. Anum, E. and Adera, T. ( 2004) Hypercholesterolemia and coronary heart disease in the elderly: a meta-analysis. Ann Epidemiol 14: 705-721.
3. Benfante, R. and Reed, D. ( 1990) Is elevated serum cholesterol level a risk factor for coronary heart disease in the elderly? JAMA 263: 393-396.
4. Berge, K.G. and Canner, P.L. ( 1991) Coronary drug project: experience with niacin. Eur J Clin Pharmacol 40: S49-S51.
5. Christensen, K., Doblhammer, G., Rau, R. and Vaupel, J.W. (2009) Ageing populations: the challenges ahead. Lancet 374: 1196-1208.
6. Downs, J.R., Clearfield, M., Weis, S., Whitney, S., Shapiro, D.R., Beere, P.A. et al. (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: result of AFCAPS/TexCAPS. Air Force / Texas Coronary Atherosclerosis Prevention Study. JAMA 279: 1615-1622.
7. Cholesterol Treatment Trialists’ (CTT) Collaborators ( 2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90056 participants in 14 randomised trials of statins. Lancet 366: 1267-1278.
8. Ericsson, S., Eriksson, M., Vitols, S., Einarsson, K., Berglund, L., Angelin, B. et al. (1991) Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J Clin Invest 87: 591-596.
9. Ferrara, A. and Barrett-Connor, S.J. ( 1997) Total LDL and HDL cholesterol decrease with age in older men and women. The Rancho Bernardo Study 1984-1994. Circulation 96: 37-43.
10. Frost, P.H., Davis, B.R., Burlando, A.J., Curb, J.D., Guthrie, G.P., Isaacsohn, J.L. et al. (1996) Serum lipids and incidence of coronary heart disease: findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation 94: 2381-2388.
11. Fruchart, J.-C., Sacks, F.M., Hermans, M.P., Assmann, G., Brown, W.V., Ceska, W. et al. (2008) The Residual Risk Reduction Initiative: a call to action to reduce residual risk in dyslipidaemic patients. Diab Vasc Dis Res 5: 319-335.
12. Grundy, S.M., Pasternak, R., Greenland, P., Smith, S. and Fuster, V. ( 1999) Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation 34: 1348-1359.
13. Heart Protection Study Collaborative Group ( 2002) MRC / BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo controlled trial. Lancet 360: 7-22.
14. Heart Protection Study Collaborative Group (2009) Statin cost-effectiveness in the united states for people at different vascular risk levels. Circulation: Cardiovasc Quality Outcomes 2: 65-72.
15. Houmard, J.A., Weidner, M.D., Dolan, P.L., Leggett-Frazier, N., Gavigan, K.E., Hickey, M.S. et al. (1995) Skeletal muscle GLUT 4 protein concentration and aging in humans. Diabetes 44: 555-560.
16. Iversen, A., Jensen, J.S., Scharling, H. and Schnohr, P. (2009) Hypercholesterolaemia and risk of coronary heart disease in the elderly: impact of age: the Copenhagen City Heart Study. Eur J Intern Med 20: 139-144.
17. Kreisberg, R.A. and Kasim, S. ( 1987) Cholesterol metabolism and aging. Am J Med 82: 54-60.
18. LaRosa, J.C., Applegate, W., Crouse, J.R., Hunninghake, D.B., Grimm, R., Knopp, R. et al. (1994) Cholesterol lowering in the elderly. Results of the Cholesterol Reduction in Seniors Program (CRISP) pilot study. Arch Intern Med 154: 529-539.
19. Lau, W.C., Waskell, L.A., Watkins, P.B., Neer, C.J., Horowitz, K. and Hopp, A.S. ( 2003) Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interaction. Circulation 107: 32-37.
20. Launay-Vacher, V., Izzedine, H. and Deray, G. ( 2005) Statins’ dosage in patients with renal failure and cyclosporine drug-drug interactions in transplant recipient patient. Intern J Cardiology 101: 9-17.
21. Le Couteur, D.G., Cogger, V.C., McCuskey, R.S., de Cabo, R., Smedsrod, B. and Sorensen, K.K. ( 2007) Age-related changes in the liver sinusoidal endothelium: a mechanism for dyslipidemia. Ann NY Acad Sci 1114: 79-87.
22. Lindblad, U., Langer, R.D., Wingard, D.L., Thomas, R.G. and Barrett-Connor, E.L. ( 2001) Metabolic syndrome and ischemic heart disease in elderly men and women. Am J Epidemiol 153: 481-489.
23. Maher, V.W., Brown, B.G., Marcovina, S.M., Hillger, L.A., Zhao, X.-Q., Albers, J.J. et al. (1995) Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a). JAMA 274: 1771-1774.
24. Malenka, D.J. and Baron, J.A. ( 1988) Cholesterol and coronary heart disease: the importance of patient-specific attributable risk. Arch Intern Med 148: 2247-2252.
25. Manolio, T.A., Pearson, T.A., Wenger, N.K., Barrett-Connor, E., Payne, G.H. and Harlan, W.R. ( 1992) Cholesterol and heart disease in older persons and women: review of an NHLBI Workshop. Ann Epidemiol 2: 161-176.
26. Merz, T. and Fuller, S.H. ( 2007) Elevated serum transaminase levels resulting from concomitant use of rosuvastatin and amiodarone. Am J Health-Syst Pharm 64: 1818-1821.
27. Miettinen, T.A., Pyorala, K., Olsson, A.G., Musliner, T.A., Cook, T.J., Faergeman, O. et al. (1997) Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 96: 4211-4218.
28. Neil, H.A., de Micco, D.A., Luo, D., Betterridge, D.J., Colhoun, H.M., Durrington, P.N. et al. (2006) Analysis of efficacy and safety in patients aged 65-75 years at randomization: Collaborative Atorvastatin Diabetes Study (CARDS). Diabetes Care 29: 2378-2384.
29. Sacks, F.M., Pfeffer, M.A., Moye, L.A., Rouleau, J.L., Rutherford, J.D., Cole, T.G. et al. (1996) The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 335: 1001-1009.
30. Santinga, J.T., Rosman, H.S., Rubenfire, M., Maciejko, J.J., Kobylak, L., McGovern, M.E. et al. (1994) Efficacy and safety of pravastatin n the long-term treatment of elderly patients with hypercholesterolemia. Am J Med 96: 509-515.
31. Sattar, N., Preiss, D., Murray, H.M., Welsh, P., Buckley, B.M., de Craen, A.J.M. et al. (2010) Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet in press.
32. Sawabe, M., Tanaka, N., Nakahara, K., Hamamatsu, A., Chida, K., Arai, T. et al. (2009) High lipoprotein (a) level promotes both coronary atherosclerosis and myocardial infarction: a path analysis using a large number of autopsy cases. Heart 95: 1997-2002.
33. Sever, P.S., Dahlof, B., Poulter, N.R., Wedel, H., Beevers, G., Caulfield, M. et al. (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomized controlled trial. Lancet 361: 1149-1158.
34. Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M. et al. (2002) Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 360: 1623-1630.
35. Shepherd, J., Cobbe, S.M., Ford, I., Isles, C.G., Lorimer, A.R., MacFarlane, P.W. et al. (1995) Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333: 1301-1307.
36. Sorrentino, S.A., Besler, C., Rohrer, L., Meyer, M., Heinrich, K., Bahlmann, F.H. et al. (2010) Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy. Circulation 121: 110-122.
37. Sukhija, R., Prayaga, S., Marashdeh, M., Bursac, Z., Kakar, P., Bansal, D. et al. (2009) Effect of statin on fasting plasma glucose in diabetic and nondiabetic patients. J Invest Med 57: 495-499.
38. Taylor, A.J., Villines, T.C., Stanek, E.J., Devine, P.J., Griffen, L., Miller, M. et al. (2009) Extended-release or ezetimibe and carotid intima-media thickness. N Engl J Med 361: 2113-2122.
39. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339: 1349-1357.
40. Tziomalos, K., Athyros, V.G., Wierzbicki, A.S. and Mikhailidis, D.P. (2009) Lipoprotein a: where are we now? Current Opin Cardiol 24: 351-357.
41. Wagstaff, L.R., Mitton, M.W., Arvik, B.M. and Doraiswamy, P.M. ( 2003) Statin-associated memory loss: analysis of 60 case reports and review of the literature. Pharmacotherapy 23: 871-880.